Hims
Publicly traded (NYSE: HIMS) telehealth company offering GLP-1 weight loss treatments alongside men's and women's health services. Offers both compounded and brand-name GLP-1 options.
Overview
- Consultation Model
- Async Telehealth
- Headquarters
- San Francisco, CA
- Shipping
- 3-5 business days
- Lab Testing
- No
- Prescriber Info
- Board-certified physicians and licensed providers evaluate patients via asynchronous medical questionnaire.
- Founded
- 2017
Pros
- Publicly traded company with financial transparency
- Massive scale — millions of customers across health verticals
- Both compounded and brand-name options
- Free provider consultations included
Cons
- No video consultations
- No lab testing included
- GLP-1 only — no other peptides
- Compounded medication availability may vary by state
Pricing
| Medication | Dose | Price | Billing |
|---|---|---|---|
| semaglutide | 0.25-2.4mg/week | $199 | monthly |
| tirzepatide | 2.5-15mg/week | $399 | monthly |